These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1378337)

  • 1. The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation.
    Lembeck F; Donnerer J; Tsuchiya M; Nagahisa A
    Br J Pharmacol; 1992 Mar; 105(3):527-30. PubMed ID: 1378337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the participation of glutamate in reflexes involving afferent, substance P-containing nerve fibres in the rat.
    Juránek I; Lembeck F
    Br J Pharmacol; 1996 Jan; 117(1):71-8. PubMed ID: 8825345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist.
    Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1992 Feb; 105(2):261-2. PubMed ID: 1373095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
    Piedimonte G; Bertrand C; Geppetti P; Snider RM; Desai MC; Nadel JA
    J Pharmacol Exp Ther; 1993 Jul; 266(1):270-3. PubMed ID: 7687291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK-1, but not NK-2, tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw: demonstrated with the NK-1 antagonist CP-96,345 and the NK-2 antagonist Men 10207.
    Xu XJ; Dalsgaard CJ; Maggi CA; Wiesenfeld-Hallin Z
    Neurosci Lett; 1992 May; 139(2):249-52. PubMed ID: 1319017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.
    Moussaoui SM; Montier F; Carruette A; Blanchard JC; Laduron PM; Garret C
    Br J Pharmacol; 1993 May; 109(1):259-64. PubMed ID: 7684305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of substance P but not nitric oxide or calcitonin gene-related peptide in neurogenic plasma extravasation in rat incisor pulp and lip.
    Kerezoudis NP; Olgart L; Edwall L
    Arch Oral Biol; 1994 Sep; 39(9):769-74. PubMed ID: 7528497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors.
    Constantine JW; Lebel WS; Woody HA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):471-7. PubMed ID: 1722563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence for tachykinin NK1 receptor-mediated neutrophil accumulation in the rat cutaneous microvasculature by thermal injury.
    Pintér E; Brown B; Hoult JR; Brain SD
    Eur J Pharmacol; 1999 Mar; 369(1):91-8. PubMed ID: 10204686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK1 receptors.
    Eglezos A; Giuliani S; Viti G; Maggi CA
    Eur J Pharmacol; 1991 Dec; 209(3):277-9. PubMed ID: 1665800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An examination of neurogenic mechanisms involved in mustard oil-induced inflammation in the mouse.
    Grant AD; Pinter E; Salmon AM; Brain SD
    Eur J Pharmacol; 2005 Jan; 507(1-3):273-80. PubMed ID: 15659318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CP-96,345, a non-peptide antagonist of substance P: II. Actions on substance P-induced hypotension and bronchoconstriction, and on depressor reflexes in mammals.
    Griesbacher T; Donnerer J; Legat FJ; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):323-7. PubMed ID: 1383835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK1 receptors mediate tachykinin-induced increase in microvascular clearance in hamster cheek pouch.
    Gao XP; Robbins RA; Snider RM; Lowe J; Rennard SI; Anding P; Rubinstein I
    Am J Physiol; 1993 Aug; 265(2 Pt 2):H593-8. PubMed ID: 7690191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CP-96,345 antagonism of NK1 receptors and smoke-induced protein extravasation in relation to its cardiovascular effects.
    Delay-Goyet P; Franco-Cereceda A; Gonsalves SF; Clingan CA; Lowe JA; Lundberg JM
    Eur J Pharmacol; 1992 Nov; 222(2-3):213-8. PubMed ID: 1280591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.
    Snider RM; Longo KP; Drozda SE; Lowe JA; Leeman SE
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10042-4. PubMed ID: 1719543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK1 receptors mediate neurogenic inflammatory increase in blood flow in rat airways.
    Piedimonte G; Hoffman JI; Husseini WK; Snider RM; Desai MC; Nadel JA
    J Appl Physiol (1985); 1993 May; 74(5):2462-8. PubMed ID: 7687598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw.
    Xu XJ; Hao JX; Wiesenfeld-Hallin Z; Håkanson R; Folkers K; Hökfelt T
    Neuroscience; 1991; 42(3):731-7. PubMed ID: 1720225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CP-96,345, a non-peptide antagonist of substance P. III. Cardiovascular effects in mammals unrelated to actions on substance P receptors.
    Donnerer J; Stark U; Tritthart HA; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):328-32. PubMed ID: 1383836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice.
    Németh J; Reglödi D; Pozsgai G; Szabó A; Elekes K; Pintér E; Szolcsányi J; Helyes Z
    Neuroscience; 2006 Nov; 143(1):223-30. PubMed ID: 16938409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice.
    Grady EF; Yoshimi SK; Maa J; Valeroso D; Vartanian RK; Rahim S; Kim EH; Gerard C; Gerard N; Bunnett NW; Kirkwood KS
    Br J Pharmacol; 2000 Jun; 130(3):505-12. PubMed ID: 10821777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.